| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.30B | +26.1% |
| Cost of Revenue | $749.2M | +25.4% |
| R&D Expense | $75.2M | -1.8% |
| SG&A Expense | $159.6M | -33.7% |
| Operating Income | $263.8M | +294.7% |
| Pre-tax Income | $51.6M | +112.3% |
| Income Tax | -$19.7M | -180.3% |
| Net Income | $81.4M | +120.3% |
| EPS (Basic) | $0.99 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $235.3M | +25.2% |
| Total Assets | $1.55B | +19.7% |
| Total Liabilities | $960.5M | +23.9% |
| Stockholders' Equity | $480.0M | +47.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $238.6M | +258.7% |
| Capital Expenditures | $13.9M | -21.6% |
| Investing Cash Flow | -$309.7M | +37.9% |
| Financing Cash Flow | $129.6M | -70.3% |
| Free Cash Flow | $224.7M | +360.6% |
| +117.5% |
| EPS (Diluted) | $0.93 | +116.4% |